In this video, I interview William (Bill) Harris, Ph.D., an internationally recognized expert on omega-3 fatty acids. He’s been studying omega-3s since 1980 and has published more than 300 scientific papers on fatty acids and health. Three years ago, he founded the Fatty Acid Research Institute (FARI)1 in South Dakota, which specializes in epidemiological research,… Read More »
In the U.S., 41.9% of adults are considered obese, with prevalence increasing from significantly in recent decades.1 What’s driving this public health epidemic is the burning question, with a wide range of factors, from ultraprocessed foods and linoleic acid to environmental chemicals, likely playing prominent roles. In a “60 Minutes” episode hosted by Lesley Stahl,2… Read More »
Colorado health officials are investigating plague activity across a handful of counties, with plague-related causes behind the death of a child. The Colorado Department of Public Health and Environment noted lab-confirmed reports of plague-infected fleas and animals in areas including La Plata County, where the 10-year-old died. Plague, caused by the bacteria Yersinia pestis, can… Read More »
Research has shown that individuals can reduce the risk of heart disease significantly by eating only 1 cup of vegetables rich in nitrates every day. The research looked at if individuals who regularly consumed higher amounts of nitrate-rich veggies like beetroot and leafy greens, had reduced blood pressure, as well as looking at whether if… Read More »
The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s… Read More »
May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other anemias, as well as thalassemia – BOSTON, May 1, 2021 /PRNewswire/ — Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced today… Read More »
Tick-borne encephalitis is a disease just as nasty as it sounds. Once bitten by an infected tick, some people develop flu-like symptoms that resolve quietly but leave behind rampant neurological disease — brain swelling, memory loss, and cognitive decline. Cases are on the rise in Central Europe and Russia with some 10,000 incidents reported each… Read More »